Mirtazapine
Product Images NDC 61919-155

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 61919-155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

155 (155 30)

Packaging label of MIRTAZAPINE 45 mg tablets, 30 count, labeled as generic for REMERON. Each tablet contains 45 mg of mirtazapine. The label includes the NDC 61919-155-30, lot number, expiration date (08/19), and packaging information by Direct Rx, Alpharetta, GA. The label also has a warning about medication storage and child safety.*

FDA Label Image

Image Description (Molecule)

Chemical structure diagram of mirtazapine, showing the molecular arrangement with interconnected rings and nitrogen atoms, including a methyl group attached to a piperazine ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.